Bio2Brain comprises a collection of 13 innovative research projects addressing the development of novel systems for the delivery of active pharmaceutical ingredients to the brain via the intranasal route/ the intranasal delivery of biopharmaceuticals to the brain via the olfactory region. The research and training programme covers the development of new advanced materials, formulations, and engineered proteins for the intranasal CNS delivery of monoclonal antibodies (mAbs). Find out more about the challenge, the individual research projects, and all publications.
